Hospital
Mymichigan Medical Center Sault
Mymichigan Medical Center Sault was paid $13.47M by Medicaid between Jan 2018 and Dec 2024, across 280 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 19% of everything it billed.
33Billing provider infoMYMICHIGAN MEDICAL CENTER SAULT
SAULT SAINTE MARIE, MI 49783
SAULT SAINTE MARIE, MI 49783
33aNPI1295756948assigned 07/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.47M
24GClaims507,777
24DCodes billed280
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#57 of 86
Median peer was paid$21.55M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JAMES, SARAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 67,239 | $1.60M | |
| 2019 | 63,740 | $1.66M | |
| 2020 | 65,401 | $1.70M | |
| 2021 | 77,795 | $2.24M | |
| 2022 | 88,651 | $2.42M | |
| 2023 | 84,433 | $2.22M | |
| 2024incomplete | 60,518 | $1.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19% | 40,207 | 33,152 | $2.50M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 9,285 | 8,472 | $1.86M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 12,115 | 11,365 | $1.55M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 4,676 | 4,349 | $1.31M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.1% | 21,483 | 5,428 | $554K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 5,406 | 4,850 | $474K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.2% | 4,520 | 2,801 | $437K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 3,600 | 3,485 | $264K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 4,656 | 3,707 | $260K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 1,509 | 1,452 | $232K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 1,798 | 1,395 | $207K |
| 59025 | Fetal non-stress test | 1.1% | 1,610 | 814 | $155K |
268 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 5,006 | $154K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 1,514 | $151K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 3,083 | $138K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,678 | $133K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,181 | $127K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,798 | $114K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,103 | $111K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 5,720 | $104K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,198 | $87K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,384 | $86K |
| 97161 | <1% | 1,745 | $84K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 760 | $72K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,050 | $71K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,198 | $70K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,770 | $68K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,977 | $68K |
| 80053 | Comprehensive metabolic panel | <1% | 24,106 | $68K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 129 | $67K |
| 80061 | Lipid panel | <1% | 6,611 | $67K |
| 87428 | <1% | 1,775 | $63K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,295 | $63K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,518 | $58K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,511 | $58K |
| 86900 | <1% | 1,792 | $56K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 38,223 | $53K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 440 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,924 | $51K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,721 | $50K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 143 | $49K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 919 | $46K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 363 | $45K |
| 76830 | Ultrasound, transvaginal | <1% | 704 | $42K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 658 | $41K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,923 | $40K |
| 86870 | <1% | 334 | $40K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,418 | $36K |
| 62323 | <1% | 106 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,078 | $36K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 546 | $34K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 802 | $33K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 2,593 | $30K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 230 | $27K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 92 | $24K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,328 | $24K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,671 | $23K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 180 | $23K |
| 96367 | <1% | 436 | $22K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,209 | $21K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 357 | $21K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,147 | $21K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,088 | $20K |
| 73564 | <1% | 940 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,460 | $19K |
| 82607 | <1% | 2,845 | $18K | |
| 87070 | <1% | 5,150 | $18K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,035 | $18K |
| 82728 | <1% | 3,021 | $17K | |
| 73630 | <1% | 1,099 | $16K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,359 | $16K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,279 | $16K |
| 87400 | <1% | 2,163 | $15K | |
| 73610 | <1% | 871 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,407 | $14K |
| 84439 | <1% | 3,451 | $14K | |
| 97602 | <1% | 187 | $13K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 47 | $13K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 962 | $12K |
| 87186 | <1% | 3,613 | $12K | |
| 86780 | <1% | 1,578 | $12K | |
| 73130 | <1% | 749 | $11K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 49 | $11K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 164 | $10K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 805 | $9K |
| 82746 | <1% | 1,472 | $9K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $9K |
| 86803 | <1% | 1,529 | $8K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 125 | $8K |
| 73110 | <1% | 421 | $7K | |
| 80306 | <1% | 4,546 | $7K | |
| 81001 | <1% | 14,350 | $7K | |
| 87088 | <1% | 2,315 | $6K | |
| 90686 | <1% | 363 | $6K | |
| 87077 | <1% | 2,301 | $6K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 721 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,189 | $6K |
| 83735 | <1% | 5,129 | $6K | |
| 85027 | <1% | 3,143 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,550 | $5K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 831 | $5K |
| 73030 | <1% | 427 | $5K | |
| 87340 | <1% | 2,053 | $5K | |
| 83540 | <1% | 1,714 | $5K | |
| 76536 | <1% | 76 | $4K | |
| 83880 | <1% | 974 | $4K | |
| 84466 | <1% | 744 | $4K | |
| 97165 | <1% | 70 | $4K | |
| 86140 | <1% | 4,781 | $4K | |
| 73221 | <1% | 31 | $4K | |
| 87210 | <1% | 1,419 | $4K | |
| 84702 | <1% | 874 | $4K | |
| 97597 | <1% | 39 | $3K | |
| 86706 | <1% | 693 | $3K | |
| 90837 | Psychotherapy session, about an hour | <1% | 37 | $3K |
| 71250 | <1% | 38 | $3K | |
| 81025 | <1% | 4,506 | $3K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 39 | $3K |
| 85610 | <1% | 3,652 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 140 | $3K |
| 20611 | <1% | 17 | $3K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 238 | $3K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 175 | $2K |
| 82570 | <1% | 1,143 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 36 | $2K |
| 94060 | <1% | 15 | $2K | |
| 80076 | <1% | 1,617 | $2K | |
| 74178 | <1% | 12 | $2K | |
| 99406 | <1% | 155 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 618 | $2K |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | <1% | 210 | $2K |
| 97162 | <1% | 41 | $2K | |
| 86708 | <1% | 400 | $2K | |
| 86704 | <1% | 417 | $2K | |
| 20553 | <1% | 12 | $2K | |
| 72110 | <1% | 63 | $2K | |
| 93017 | <1% | 63 | $2K | |
| 87807 | <1% | 732 | $2K | |
| 82947 | <1% | 791 | $2K | |
| 85007 | <1% | 1,784 | $2K | |
| 85652 | <1% | 1,826 | $2K | |
| 74018 | <1% | 125 | $2K | |
| 76770 | <1% | 25 | $2K | |
| 87506 | <1% | 15 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,143 | $2K |
| 87521 | Neg quan hep c or qual rna | <1% | 114 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,366 | $2K |
| 82784 | <1% | 186 | $2K | |
| 76642 | <1% | 36 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 53 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 30 | $1K |
| 86038 | <1% | 313 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 24 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 124 | $1K |
| 92551 | <1% | 212 | $1K | |
| 84481 | <1% | 180 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $1K |
| 83655 | <1% | 210 | $1K | |
| 84403 | <1% | 88 | $1K | |
| 90670 | <1% | 19 | $1K | |
| 83690 | <1% | 3,810 | $1K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 12 | $997.08 |
| 82565 | <1% | 745 | $996.40 | |
| 87276 | <1% | 302 | $936.25 | |
| 36592 | <1% | 2,544 | $928.79 | |
| 87653 | <1% | 59 | $868.23 | |
| 85730 | <1% | 2,147 | $862.84 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 67 | $717.15 |
| 86592 | <1% | 299 | $712.68 | |
| 87275 | <1% | 301 | $705.92 | |
| 73502 | <1% | 42 | $659.64 | |
| 86850 | <1% | 1,690 | $646.04 | |
| 83970 | <1% | 50 | $631.84 | |
| 51798 | <1% | 211 | $623.42 | |
| 87081 | <1% | 262 | $585.25 | |
| 81002 | <1% | 1,061 | $571.54 | |
| 90474 | <1% | 188 | $558.00 | |
| 82950 | <1% | 209 | $557.63 | |
| 87800 | <1% | 27 | $532.78 | |
| 86709 | <1% | 84 | $500.69 | |
| 82043 | <1% | 183 | $499.99 | |
| 83550 | <1% | 120 | $489.45 | |
| 96130 | <1% | 129 | $460.85 | |
| 97035 | <1% | 77 | $446.54 | |
| 84144 | <1% | 39 | $398.54 | |
| 82150 | <1% | 523 | $345.98 | |
| 82550 | <1% | 191 | $339.65 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 49 | $300.31 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $276.04 |
| 88142 | <1% | 30 | $275.40 | |
| 84484 | <1% | 3,290 | $264.98 | |
| 86762 | <1% | 616 | $244.77 | |
| 84460 | <1% | 87 | $242.44 | |
| 84156 | <1% | 197 | $239.40 | |
| 82077 | <1% | 1,539 | $230.60 | |
| 88304 | <1% | 285 | $227.74 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 35 | $210.00 |
| 86800 | <1% | 31 | $188.29 | |
| 84550 | <1% | 139 | $182.72 | |
| 86376 | <1% | 29 | $155.86 | |
| 87808 | <1% | 24 | $150.48 | |
| 86431 | <1% | 74 | $144.86 | |
| 84100 | <1% | 129 | $109.68 | |
| 85379 | <1% | 237 | $107.12 | |
| 82951 | <1% | 15 | $105.60 | |
| 84165 | <1% | 25 | $98.24 | |
| 84703 | <1% | 73 | $94.60 | |
| 87430 | <1% | 30 | $92.00 | |
| 82248 | <1% | 93 | $87.17 | |
| 84145 | <1% | 1,112 | $86.73 | |
| 87075 | <1% | 25 | $82.88 | |
| 86334 | <1% | 12 | $66.45 | |
| 96127 | <1% | 50 | $65.12 | |
| 82962 | <1% | 2,032 | $62.21 | |
| 85018 | <1% | 85 | $61.92 | |
| 86618 | <1% | 12 | $60.78 | |
| 87328 | <1% | 12 | $49.32 | |
| 80178 | <1% | 16 | $45.65 | |
| 83615 | <1% | 31 | $42.66 | |
| 85014 | <1% | 55 | $40.02 | |
| 84155 | <1% | 25 | $33.58 | |
| 81003 | <1% | 26 | $29.13 | |
| 82310 | <1% | 12 | $27.80 | |
| 86901 | <1% | 1,790 | $25.31 | |
| 82180 | <1% | 12 | $23.52 | |
| 87040 | <1% | 156 | $23.32 | |
| 88312 | <1% | 26 | $22.75 | |
| 83605 | <1% | 1,184 | $19.01 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 26 | $5.44 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 49 | $4.55 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,204 | $3.00 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 805 | $1.18 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 671 | $0.36 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 3,478 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 2,434 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 2,936 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 2,579 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 4,591 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 1,203 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 72 | $0.00 |
| 96376 | 0% | 887 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 692 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 1,415 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 1,040 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 936 | $0.00 |
| J3490 | Unclassified drugs | 0% | 322 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 60 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 117 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 54 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 30 | $0.00 |
| 12001 | 0% | 12 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 15 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 31 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 15 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 24 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 24 | $0.00 |
| 82803 | 0% | 12 | $0.00 | |
| 90715 | 0% | 305 | $0.00 | |
| 99173 | 0% | 237 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 934 | $0.00 |
| 90685 | 0% | 83 | $0.00 | |
| 76376 | 0% | 308 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 287 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 476 | $0.00 |
| 99152 | 0% | 98 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 18 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 85 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 78 | $0.00 |
| Q0169 | Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 90 | $0.00 |
| 0353U | 0% | 223 | $0.00 | |
| 90461 | 0% | 30 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 82805 | 0% | 12 | $0.00 | |
| 90707 | 0% | 13 | $0.00 | |
| 90633 | 0% | 13 | $0.00 | |
| 94729 | 0% | 15 | $0.00 | |
| 88313 | 0% | 24 | $0.00 | |
| 80143 | 0% | 12 | $0.00 | |
| 94727 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJAMES, SARAH (MANAGER, PROVIDER ENROLLMENT)
| Provider | Location | Paid |
|---|---|---|
| Mymichigan Medical Center Midland | Midland, MI | $50.05M |
| Mymichigan Medical Center Saginaw | Saginaw, MI | $38.70M |
| Mymichigan Medical Center Alma | Alma, MI | $25.31M |
| Mymichigan Medical Center Midland | Midland, MI | $24.37M |
| Mymichigan Medical Center Alpena | Alpena, MI | $21.24M |
| Mymichigan Medical Center Clare | Clare, MI | $17.66M |
| Mymichigan Medical Center Gladwin | Gladwin, MI | $10.43M |
| Mymichigan Medical Center Tawas | Tawas City, MI | $9.11M |
| Mymichigan Medical Group | Midland, MI | $8.12M |
| Mymichigan Medical Center Standish | Standish, MI | $7.15M |
| Mymichigan Medical Group | Midland, MI | $5.09M |
| Mymichigan Medical Center Sault | Sault Sainte Marie, MI | $3.78M |
| Mymichigan Medical Center Alpena | Alpena, MI | $2.89M |
| Mymichigan Medical Center Midland | Midland, MI | $2.15M |
| Mymichigan Medical Group | Midland, MI | $2.08M |
| Mymichigan Medical Group | Midland, MI | $1.97M |
| Mymichigan Medical Center Sault | Sault Sainte Marie, MI | $1.62M |
| Mymichigan Medical Center Saginaw | Vassar, MI | $1.09M |
| Mymichigan Medical Center Standish | Standish, MI | $967K |
| Mymichigan Medical Center Saginaw | Saginaw, MI | $941K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.